Remote monitoring is increasing as new reimbursement paths open up. But even the best programs are no guarantee of success.

Medtronic Diabetes has expanded U.S. pharmacy formulary access for its MiniMed 780F insulin pump through agreements with ...

Sen. Chuck Grassley launched an investigation last year following Wall Street Journal reports examining the company’s ...

GLP-1 meds are are highly effective at treating diabetes, obesity and other conditions. But when people stop using them, the ...

Ollin Biosciences Inc. is gearing up for global phase III trials this year after disclosing favorable top-line results from its randomized, head-to-head phase Ib Jade study comparing OLN-324, a ...

Ollin Biosciences has announced positive topline results from its randomized, head-to-head Phase 1b JADE clinical study ...

Medtronic (NYSE:MDT) announced today that it expanded U.S. pharmacy formulary access for its MiniMed 780G insulin pump.

The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve ...

I would have my shoes in four to six weeks, that’s what they said,” Rebecca Blair said. That was at the end of June.

The Centers for Medicare & Medicaid Services late last year introduced the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) Model to expand access to select ...

Update: Osterhout had an appointment on Thursday. He said he was given his shoes and the wrong insoles, similar to Thomasson. TOLEDO, Ohio (WTVG) -Two men with diabetes are tired of playing the ...